Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Clinical trial NCT03126786 · COMPLETED
Trial details
- NCT number
- NCT03126786
- Sponsor
- Clearside Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2018-04-17
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.